You searched for "lashes"
Adjunctive topical 5-FU vs. MMC for surgically excised, localised OSSN
1 October 2014
| Anjali Gupta
|
EYE - Cornea, EYE - General
|
OSSN, chemotherapy, ocular oncology, ocular surface tumours
Ocular surface squamous neoplasia (OSSN) comprises a range of dysplasia including corneal-conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma. The traditional treatment for localised non-invasive OSSN has been surgical excision with or without intraoperative cryotherapy. Postoperative adjunctive topical chemotherapy significantly...
Sclerotomy suturing
1 August 2014
| Saruban Pasu
|
EYE - Vitreo-Retinal
This was a retrospective review of 589 consecutive cases of patients who underwent 23-gauge tranconjunctival pars plana vitrectomy. Cases were split into Type 1 vitrectomies (macular hole, ERM and simple vitreous haemorrhages) and Type 2 cases which were more complex...
Management and outcomes of congenital fibrovascular pupillary membranes (CFPM)
Congenital fibrovascular pupillary membranes (CFPM) is defined as a white fibrous membrane across the pupil which may be an ectopic iris tissue arising from the aberrant migration of neural crest cells or a variant of persistent fetal vasculature. The authors...Does Duane syndrome have an effect on refractive error?
The authors present a retrospective case review from a database created from a 43-year period of patients with strabismus seen by a single ophthalmologist. Cases were reviewed by either an orthoptist or ophthalmologist for entry into the database. Details relating...Efficacy of BT as a treatment for cranial nerve palsy in acute and chronic cases
The authors performed a meta-analysis of all patients’ treatment with botulinum toxin (BT) for cranial nerve palsy (CNP) to determine the efficacy of BT in the treatment of CNP due to a variety of causes. The search identified 1129 articles...Modern practice options for UK ophthalmologists
When I spoke on setting up private practice at the annual United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in November ’23 there was a lot of interest in different types of practice models. If we...Sickle cell eye disease: an overview of vitreoretinal complications and their surgical management
1 December 2016
| Antonio Berarducci, Tom Williamson
|
EYE - Vitreo-Retinal
Sickle cell disease is the most common genetic disorder worldwide and is associated with lifelong anaemia, intermittent pain and multi-organ morbidity. Ocular involvement can be associated with significant visual impairment due to the complications of proliferative sickle retinopathy (PSR). Occasionally...
The Preston Rule
27 July 2021
| Andrew King
|
EYE - General
The selection, specification and fitting of a spectacle frame necessitates the recording of certain measurements particular to the frame. These measurements are also essential when it is required to manufacture a handmade spectacle frame. Instruments designed to accomplish this task...
The International Council of Ophthalmology: what is it and is it useful for UK ophthalmologists?
1 April 2018
| Simon Keightley
|
EYE - General
ICO Director for Examinations and Assessments, Simon Keightley, explains the history and role of the organisation today, as well as outlining recent changes to the ICO examinations. The International Council of Ophthalmology (ICO) is the only international medical specialty organisation...
CALL TO ACTION: Ophthalmology on Myanmar / Thailand border: do you have any redundant kit?
29 June 2023
| Kate Claridge
|
EYE - General
In 1990, the late Doctor Frank Green, a consultant ophthalmologist in Aberdeen, along with Doctor Phillip Ambler, a GP with ophthalmic training, responded to an invitation to provide ophthalmic care for Karen refugees on the northern and eastern Myanmar borders....
Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service
3 April 2023
| Yasir Khan, Robin Hamilton, Adam Mapani, Catey Bunce, Ranjan Rajendram, Carlos Pavesio
|
EYE - General
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...
Part 1: Good news, bad news at the international conference
3 June 2024
| Peter Cackett
|
EYE - General
One of my favourite comic strips from my childhood was Good News, Bad News which ran in Jackpot comic from 1979–1982. In this strip, the story for the main character would be described in a series of alternating ‘Good News’...